MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Caregiver burden in patients with Parkinson disease

S. Tomic, J. Kragujevic, Z. Popijac, V. Pekic (Osijek, Croatia)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1164

Keywords: Parkinson’s

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: To analyze caregiver burden in PD patients in respect to patient`s quality of life, disease stage and treatment option.

Background: Parkinson`s disease (PD) is neurodegenerative disease causing loss of patient`s independence, need for continuos care and burden of caregiver.

Method: Patients treated on in- and out-patient clinic were included. They were divided into the three groups: early stage (ES), advanced stage on peroral drugs treatment (AS-PO) and advanced stage treated with pump (AS-P). Demographic data were collected. All the patients were survey for quality of life (QoL) using Parkinson`s disease Questionairre 8 (PDQ-8), while all caregivers were survey for burden using Zarit burden interview 22 (ZBI 22).

Results: We have analyzed 51 PD patients and 51 caregivers. There was difference in QoL between ES and AS-PO (p<0.007) and ES and AS-P (p<0.002). Disease duration and duration of care correlate positively with patients QoL and caregiver burden and with relationship caregiver-patient. Patient`s QoL correlate positively with caregiver health, psyhcological well-being, social life and relationship caregiver-patient. There was no difference in caregiver burden according to patient`s neither caregiver age or correlation between burden with patients group (ES, AS-PO and AS-P).

Conclusion: Disease duration and duration of care influence negatively on patient`s QoL, caregiver burden and relationship caregiver-patient. Disease stage nor treatment option do not increased caregiver burden, while advance disease stage (AS-PO and AS-P) influence negatively on patients QoL. Lower patient`s QoL influence negatively on most aspects of caregiver life including health, psychological well-being, social life and relationship caregiver-patient.

To cite this abstract in AMA style:

S. Tomic, J. Kragujevic, Z. Popijac, V. Pekic. Caregiver burden in patients with Parkinson disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/caregiver-burden-in-patients-with-parkinson-disease/. Accessed June 23, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/caregiver-burden-in-patients-with-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Welcome to the MDS Abstracts Site
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Life expectancy with and without Parkinson’s disease in the general population
    • The hardest symptoms that bother patients with Parkinson's disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley